TECHNICAL ANALYSIS

Hansoh Pharmaceutical Group is set to to resume its uptrend after breaking out from its 2-month rectangle pattern few sessions ago. With the stock posting 4 consecutive white candles coupled with its 20-day and 50-day EMAs are converging and are likely to turn up in the near term, a positive outlook can be expected here. We expect the rising momentum is set to steer the stock higher and test the next level of resistance of HK$13.20 and HK$14.00 in the near term.

Fundamentals

Net profit is expected to grow at a CAGR of 12% for the next 3 years with stable net margins of between 26%-27%.

Source: Rakuten Research - 17 Oct 2023

To sign up for an account: http://bit.ly/40BNqKI

[Youtube Tutorial] Account Opening & Enable Foreign Equity: http://bit.ly/3I5Jzxo